These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8328966)

  • 1. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.
    Ghiso J; Matsubara E; Koudinov A; Choi-Miura NH; Tomita M; Wisniewski T; Frangione B
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):27-30. PubMed ID: 8328966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring clusterin and fibrillar structures in aging and dementia.
    Trindade D; Cachide M; Soares Martins T; Guedes S; Rosa IM; da Cruz E Silva OAB; Henriques AG
    Aging Brain; 2023; 3():100080. PubMed ID: 37346145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer's disease.
    Young-Pearse TL; Lee H; Hsieh YC; Chou V; Selkoe DJ
    Trends Neurosci; 2023 Jun; 46(6):426-444. PubMed ID: 37019812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes of CSF clusterin levels across the Alzheimer's disease continuum.
    Tang L; Wang ZB; Ma LZ; Cao XP; Tan L; Tan MS
    BMC Neurol; 2022 Dec; 22(1):508. PubMed ID: 36581903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.
    Huntoon K; Anderson SK; Ballman KV; Twohy E; Dooley K; Jiang W; An Y; Li J; von Roemeling C; Qie Y; Ross OA; Cerhan JH; Whitton AC; Greenspoon JN; Parney IF; Ashman JB; Bahary JP; Hadjipanayis C; Urbanic JJ; Farace E; Khuntia D; Laack NN; Brown PD; Roberge D; Kim BYS
    Neuro Oncol; 2023 Jun; 25(6):1123-1131. PubMed ID: 36472389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated clusterin species facilitate Aβ toxicity in human neurons.
    Foster EM; Fernandes M; Dangla-Valls A; Hublitz P; Pangalos M; Lovestone S; Ribe EM; Buckley NJ
    Sci Rep; 2022 Nov; 12(1):18639. PubMed ID: 36329114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Clusterin Transporter in the Pathogenesis of Alzheimer's Disease at the Blood-Brain Barrier Interface: A Systematic Review.
    Fareed MM; Qasmi M; Aziz S; Völker E; Förster CY; Shityakov S
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1-42).
    Kim YM; Park S; Choi SY; Oh SB; Jung M; Pack CG; Hwang JJ; Tak E; Lee JY
    Mol Neurobiol; 2022 Oct; 59(10):6228-6244. PubMed ID: 35904715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoproteins in the Central Nervous System: From Biology to Pathobiology.
    Raulin AC; Martens YA; Bu G
    Annu Rev Biochem; 2022 Jun; 91():731-759. PubMed ID: 35303786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Targets Linked to the Cardiovascular/Alzheimer's Axis through Bioinformatics Approaches.
    Andújar-Vera F; García-Fontana C; Sanabria-de la Torre R; González-Salvatierra S; Martínez-Heredia L; Iglesias-Baena I; Muñoz-Torres M; García-Fontana B
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Insights into the Impact of Complement in Alzheimer's Disease.
    Torvell M; Carpanini SM; Daskoulidou N; Byrne RAJ; Sims R; Morgan BP
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of clusterin with the BRI2-derived amyloid molecules ABri and ADan.
    Rostagno A; Calero M; Holton JL; Revesz T; Lashley T; Ghiso J
    Neurobiol Dis; 2021 Oct; 158():105452. PubMed ID: 34298087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphene FET Sensors for Alzheimer's Disease Protein Biomarker Clusterin Detection.
    Bungon T; Haslam C; Damiati S; O'Driscoll B; Whitley T; Davey P; Siligardi G; Charmet J; Awan SA
    Front Mol Biosci; 2021; 8():651232. PubMed ID: 33869287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte-derived clusterin suppresses amyloid formation in vivo.
    Wojtas AM; Sens JP; Kang SS; Baker KE; Berry TJ; Kurti A; Daughrity L; Jansen-West KR; Dickson DW; Petrucelli L; Bu G; Liu CC; Fryer JD
    Mol Neurodegener; 2020 Nov; 15(1):71. PubMed ID: 33246484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation of Serum Clusterin in Wild-Type Transthyretin-Associated (ATTRwt) Amyloidosis: A Study of Disease-Associated Compositional Features Using Mass Spectrometry Analyses.
    Torres-Arancivia CM; Chang D; Hackett WE; Zaia J; Connors LH
    Biochemistry; 2020 Nov; 59(45):4367-4378. PubMed ID: 33141553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.
    Uddin MS; Kabir MT; Begum MM; Islam MS; Behl T; Ashraf GM
    Neurotox Res; 2021 Dec; 39(6):2108-2119. PubMed ID: 32820456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia.
    Koch M; DeKosky ST; Goodman M; Sun J; Furtado JD; Fitzpatrick AL; Mackey RH; Cai T; Lopez OL; Kuller LH; Mukamal KJ; Jensen MK
    JAMA Netw Open; 2020 Jul; 3(7):e209250. PubMed ID: 32648923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease.
    Gião T; Saavedra J; Cotrina E; Quintana J; Llop J; Arsequell G; Cardoso I
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
    Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
    Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype.
    Lana E; Gellerbring A; Jung S; Nordberg A; Unger Lithner C; Darreh-Shori T
    Front Mol Neurosci; 2019; 12():176. PubMed ID: 31417354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.